We are live on
!
Find out more
AG
Aperio Group Portfolio holdings
AUM
$33.8B
1-Year Est. Return
31.46%
This Fund
S&P 500
This Quarter
Est. Return
-0.09%
1 Year Est. Return
+31.46%
3 Year Est. Return
+70.41%
5 Year Est. Return
+146.02%
10 Year Est. Return
–
AUM
$20.1B
AUM Growth
+$425M
(+2.2%)
Cap. Flow
+$621M
Cap. Flow
% of AUM
3.09%
Top 10 Holdings %
Top 10 Hldgs %
14.31%
Holding
2,314
New
76
Increased
1,391
Reduced
773
Closed
68
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$17.1M |
| 2 |
Amazon
AMZN
|
+$16.2M |
| 3 |
AT&T
T
|
+$15.2M |
| 4 |
Alphabet (Google) Class A
GOOGL
|
+$14.2M |
| 5 |
Microsoft
MSFT
|
+$13.6M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Aflac
AFL
|
+$61.2M |
| 2 |
ExxonMobil
XOM
|
+$29.1M |
| 3 |
SYT
Syngenta Ag
SYT
|
+$19.2M |
| 4 |
Park Hotels & Resorts
PK
|
+$10.5M |
| 5 |
Intel
INTC
|
+$8.26M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Financials | 18.23% |
| 2 | Technology | 17.53% |
| 3 | Healthcare | 12.83% |
| 4 | Consumer Discretionary | 9.79% |
| 5 | Industrials | 9.27% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2026
Artivion
AORT
$1.34B
| $260K | ﹤0.01% |
12,969
-88
| -0.7% | -$1.68K |
|
2027
Ultragenyx Pharmaceutical
RARE
$2.56B
| $259K | ﹤0.01% |
5,075
-396
| -7% | -$19.9K |
|
2028
Telus
TU
$16.8B
| $259K | ﹤0.01% |
14,746
+3,442
| +30% | +$62.8K |
|
|
PHH
2029
DELISTED
PHH Corporation
PHH
| $259K | ﹤0.01% |
24,794
+4,527
| +22% | +$43.9K |
|
2030
Central Garden & Pet Co
CENT
$2.71B
| $257K | ﹤0.01% |
7,480
+534
| +8% | +$16.9K |
|
|
AJRD
2031
DELISTED
Aerojet Rocketdyne Holdings
AJRD
| $257K | ﹤0.01% |
9,186
+560
| +6% | +$15.8K |
|
2032
Heritage Financial
HFWA
$1.21B
| $256K | ﹤0.01% |
8,379
-620
| -7% | -$19.1K |
|
2033
Bank of Marin Bancorp
BMRC
$465M
| $255K | ﹤0.01% |
7,388
+754
| +11% | +$26.1K |
|
|
OCLR
2034
DELISTED
Oclaro Inc.
OCLR
| $255K | ﹤0.01% |
26,701
-2,883
| -10% | -$21.6K |
|
|
SYNH
2035
DELISTED
Syneos Health, Inc. Class A Common Stock
SYNH
| $254K | ﹤0.01% |
7,161
-8,097
| -53% | -$317K |
|
|
UBNK
2036
DELISTED
United Financial Bancorp, Inc.
UBNK
| $252K | ﹤0.01% |
15,548
+2,556
| +20% | +$42.4K |
|
2037
1st Source
SRCE
$2.16B
| $251K | ﹤0.01% |
4,951
+110
| +2% | +$5.64K |
|
|
VIA
2038
DELISTED
Viacom Inc. Class A
VIA
| $251K | ﹤0.01% |
6,331
-48
| -0.8% | -$1.83K |
|
|
ALX
2039
Alexander's
ALX
$1.36B
| $249K | ﹤0.01% |
+652
| New | +$242K |
|
2040
Sarepta Therapeutics
SRPT
$1.64B
| $249K | ﹤0.01% |
3,361
-575
| -15% | -$38.3K |
|
|
IPHS
2041
DELISTED
Innophos Holdings, Inc.
IPHS
| $248K | ﹤0.01% |
6,164
-1,162
| -16% | -$50.9K |
|
|
TI.A
2042
DELISTED
Telecom Italia 10 Svg
TI.A
| $247K | ﹤0.01% |
+29,739
| New | +$234K |
|
2043
Corcept Therapeutics
CORT
$12.7B
| $246K | ﹤0.01% |
+14,999
| New | +$278K |
|
2044
Fabrinet
FN
$15.7B
| $246K | ﹤0.01% |
+7,839
| New | +$231K |
|
|
LADR
2045
Ladder Capital
LADR
$1.23B
| $246K | ﹤0.01% |
+16,330
| New | +$239K |
|
2046
Viasat
VSAT
$10.7B
| $246K | ﹤0.01% |
3,745
-311
| -8% | -$22.7K |
|
2047
Chord Energy
CHRD
$7.78B
| $245K | ﹤0.01% |
30,291
-5,689
| -16% | -$48K |
|
2048
Zillow
Z
$7.71B
| $245K | ﹤0.01% |
+4,557
| New | +$220K |
|
|
DOOR
2049
DELISTED
MASONITE INTERNATIONAL CORP
DOOR
| $245K | ﹤0.01% |
3,991
-1,192
| -23% | -$80.2K |
|
2050
Archrock
AROC
$6.21B
| $244K | ﹤0.01% |
27,884
-3,520
| -11% | -$33.6K |
|
Similar funds
OU
CTA
GAM
CCI
SWM
LCM
HCMNY
BII
Aperio Group's Q1 2018 Portfolio in Review
As of Q1 2018, Aperio Group held 2,314 positions worth $20.1B, up 2.2% from $19.7B the previous quarter. Its ten largest holdings account for 14% of the portfolio.
Aperio Group deployed $621M of net new capital in Q1 2018, opening 76 new positions and adding to 1,391 existing holdings. Its largest new stake was Nutrien: 225,586 shares worth $10.7M.
By sector, the portfolio is most concentrated in Financials at 18% of assets, up from 18% a quarter earlier, followed by Technology and Healthcare.
On the sell side, the largest reduction was Aflac, an estimated $61.2M trimmed.
- Aperio Group's largest Q1 2018 buy was Nutrien: 225,586 shares worth $10.7M.
- Aperio Group added most to Apple in Q1 2018, an estimated $17.1M increase.
- Aperio Group's biggest Q1 2018 reduction was Aflac, cutting an estimated $61.2M.
- Aperio Group fully exited Syngenta Ag in Q1 2018, selling an estimated $19.2M.
- Aperio Group's ten largest holdings make up 14% of its $20.1B portfolio in Q1 2018.
- Aperio Group opened 76 new positions and closed 68 in Q1 2018.
- Aperio Group's portfolio value rose 2.2% quarter-over-quarter to $20.1B.
Based on Aperio Group's 13F filing for Q1 2018, filed 8 May 2018.